The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Infectious Diseases

• Publication date

  2011-07-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1093/infdis/jiq006PMID 21628665PMCID PMC3307152
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative Role of Aedes albopictus and Aedes aegypti in the Emergence of Dengue and Chikungunya in Central Africa

  2010cited by this paper
• Persistent Chronic Inflammation and Infection by Chikungunya Arthritogenic Alphavirus in Spite of a Robust Host Immune Response

  2010influential reference
• Active Infection of Human Blood Monocytes by Chikungunya Virus Triggers an Innate Immune Response

  2010cited by this paper
• Type I IFN controls chikungunya virus via its action on nonhematopoietic cells

  2010influential reference
• IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity

  2009influential reference
• Chikungunya virus of Asian and Central/East African genotypes in Malaysia.

  2009cited by this paper
• Aedes albopictus, an arbovirus vector: from the darkness to the light.

  2009cited by this paper
• Type I interferon induction is correlated with attenuation of a South American eastern equine encephalitis virus strain in mice.

  2009cited by this paper
• Recently introduced Aedes albopictus in Corsica is competent to Chikungunya virus and in a lesser extent to dengue virus

  2009cited by this paper
• Entomologic and Virologic Investigation of Chikungunya, Singapore

  2009cited by this paper
• Concurrent Chikungunya and Dengue Virus Infections during Simultaneous Outbreaks, Gabon, 2007

  2009cited by this paper
• A Mouse Model for Chikungunya: Young Age and Inefficient Type-I Interferon Signaling Are Risk Factors for Severe Disease

  2008cited by this paper
• Aedes albopictus, vecteur des virus du chikungunya et de la dengue à la Réunion : biologie et contrôle

  2008cited by this paper
• Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus.

  2008cited by this paper
• [Aedes albopictus, vector of chikungunya and dengue viruses in Reunion Island: biology and control].

  2008cited by this paper
• Chikungunya virus adapts to tiger mosquito via evolutionary convergence: a sign of things to come?

  2008cited by this paper
• Host responses to alphavirus infection

  2008cited by this paper
• Prospective Study of Chikungunya Virus Acute Infection in the Island of La Réunion during the 2005–2006 Outbreak

  2008cited by this paper
• Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures.

  2008cited by this paper
• Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus.

  2007cited by this paper
• Characterization of Reemerging Chikungunya Virus

  2007influential reference
• Infection with chikungunya virus in Italy: an outbreak in a temperate region.

  2007cited by this paper
• Non-pathogenic Sindbis virus causes hemorrhagic fever in the absence of alpha/beta and gamma interferons.

  2007cited by this paper
• Chikungunya, an epidemic arbovirosis.

  2007cited by this paper
• Chikungunya epidemic in India: a major public-health disaster.

  2007cited by this paper
• Semliki Forest Virus Nonstructural Protein 2 Is Involved in Suppression of the Type I Interferon Response

  2007cited by this paper
• Chikungunya outbreaks--the globalization of vectorborne diseases.

  2007cited by this paper
• Chikungunya Fever, Hong Kong

  2006cited by this paper
• Chikungunya, l'épidémie que l'on n'attendait pas

  2006cited by this paper
• Aedes albopictus as an epidemic vector of chikungunya virus: another emerging problem?

  2006cited by this paper
• Resurgence of chikungunya virus in India: an emerging threat.

  2006cited by this paper
• The Old World and New World Alphaviruses Use Different Virus-Specific Proteins for Induction of Transcriptional Shutoff

  2006cited by this paper
• [The unexpected Chikungunya outbreak].

  2006cited by this paper
• Chikungunya Virus Strains, Reunion Island Outbreak

  2006cited by this paper
• Re-emergence of chikungunya virus in India.

  2006cited by this paper
• Genome Microevolution of Chikungunya Viruses Causing the Indian Ocean Outbreak

  2006cited by this paper
• Chikungunya outbreak in Reunion: epidemiology and surveillance, 2005 to early January 2006.

  2006cited by this paper
• Epidemic resurgence of Chikungunya virus in democratic Republic of the Congo: Identification of a new central African strain

  2004cited by this paper
• [Epidemic of Chikungunya virus in 1999 and 200 in the Democratic Republic of the Congo].

  2003cited by this paper
• Roles of Nonstructural Protein nsP2 and Alpha/Beta Interferons in Determining the Outcome of Sindbis Virus Infection

  2002cited by this paper
• An Arthrogenic Alphavirus Induces Monocyte Chemoattractant Protein-1 and Interleukin-8

  2000cited by this paper
• Alpha/Beta Interferon Protects Adult Mice from Fatal Sindbis Virus Infection and Is an Important Determinant of Cell and Tissue Tropism

  2000cited by this paper
• Infection of Neonatal Mice with Sindbis Virus Results in a Systemic Inflammatory Response Syndrome

  1999cited by this paper
• Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.

  1997cited by this paper
• Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation

  1995cited by this paper
• Aedes furcifer and other mosquitoes as vectors of chikungunya virus at Mica, northeastern Transvaal, South Africa.

  1990cited by this paper
• Mononuclear cell types in chronic synovial effusions of Ross River virus disease.

  1984cited by this paper
• Chikungunya virus infection. A retrospective study of 107 cases.

  1983cited by this paper
• Laboratory vector studies on six mosquito and one tick species with chikungunya virus.

  1981cited by this paper
• An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features.

  1955cited by this paper
• Identification and Characterization of Interferon-Induced Proteins That Inhibit Alphavirus Replication (cid:1)

  year unknowncited by this paper

• Single-Cell Sequencing Reveals the Immune Characteristics of Secondary Liver Injury Induced Indirectly by CHIKV Infection in Rhesus Macaques.

  2026cites this paper
• Rewiring of host cell signaling in chikungunya virus infection: a mechanism for pathogenesis and therapeutic approaches

  2026cites this paper
• Engineered VPg saRNA achieves cap-independent, low-immunogenic and precise encoding of therapeutic proteins in vivo

  2026cites this paper
• Chikungunya Virus in 2025: Epidemiology, Immunopathogenesis, and Vaccine Development — A Narrative Review

  2026cites this paper
• Pro-Inflammatory Cytokines as Early Predictors of Chronic Rheumatologic Disease Following Chikungunya Virus Infection

  2025cites this paper
• Cannabidiol promotes fine-tuning of natural killer and monocytic cells subsets as well as cytokine storm during chikungunya virus exposure in vitro: Insights for putative therapeutic interventions.

  2025cites this paper
• Diagnosis of Chikungunya infection: a Narrative Review

  2025cites this paper
• Pro inflammatory IL-1β: A potential biomarker for chronic chikungunya arthritis condition.

  2025cites this paper
• Granulocyte colony-stimulating factor protects against acute systemic alphavirus disease in a type I IFN-dependent manner

  2025cites this paper
• Exploiting the chikungunya virus capsid protein: a focused target for antiviral therapeutic development

  2025cites this paper
• A Review of the Biology of Chikungunya Virus Highlighting the Development of Current Novel Therapeutic and Prevention Approaches

  2025cites this paper
• Chikungunya Virus: Unveiling Its Global Impact (2002–2024)

  2025cites this paper
• A Roadmap Towards the Identification and Validation of Conserved T Cell Epitope Regions in Viral Pathogen Families with Pandemic Potential.

  2025cites this paper
• Current and future advances in practice: arboviral arthritides

  2025influential citation
• Emetine dihydrochloride inhibits Chikungunya virus nsP2 helicase and shows antiviral activity in the cell culture and mouse model of virus infection

  2025cites this paper
• Chikungunya virus and other emerging arthritogenic alphaviruses

  2025cites this paper
• Attenuation of Chikungunya Virus by a Single Amino Acid Substitution in the nsP1 Component of a Non-Structural Polyprotein

  2025cites this paper
• Chikungunya fever: pathogenesis and mechanisms underlying pain symptoms

  2025cites this paper
• Chikungunya virus infection in the skin: histopathology and cutaneous immunological response

  2025cites this paper
• Time Series Analysis of Dengue, Zika, and Chikungunya in Ecuador: Emergence Patterns, Epidemiological Interactions, and Climate-Driven Dynamics (1988–2024)

  2025cites this paper
• Comparing human pediatric immune responses to primary infection with dengue, chikungunya and Zika viruses

  2025cites this paper
• Multiorgan proteomic analysis of infected animal models predict potential host factors for chikungunya virus

  2025cites this paper
• Arboviruses: the hidden danger of the tropics

  2025cites this paper
• Unraveling the Complexity of Chikungunya Virus Infection Immunological and Genetic Insights in Acute and Chronic Patients

  2024cites this paper
• Current diagnostics and biomarkers for arboviral infections (a review on Dengue, Zika, West Nile and Chikungunya viruses)

  2024cites this paper
• Chronic chikungunya disease (CCD): clinical insights, immunopathogenesis and therapeutic perspectives

  2024cites this paper
• Balancing functions of regulatory T cells in mosquito-borne viral infections

  2024cites this paper
• Current challenges in the discovery of treatments against Mayaro fever

  2024cites this paper
• Chronic Rheumatologic Disease in Chikungunya Virus Fever: Results from a Cohort Study Conducted in Piedecuesta, Colombia

  2024cites this paper
• Comparison of Chikungunya Virus-Induced Disease Progression and Pathogenesis in Type-I Interferon Receptor-Deficient Mice (A129) and Two Wild-Type (129Sv/Ev and C57BL/6) Mouse Strains

  2024cites this paper
• Infectomics of Chikungunya Virus: Roles Played by Host Factors.

  2024cites this paper
• Granulocyte colony-stimulating factor protects against arthritogenic alphavirus pathogenesis in a type I IFN-dependent manner

  2024cites this paper
• Pathogenicity and virulence of chikungunya virus

  2024cites this paper
• Viremia and clinical manifestations in acute febrile patients of Chikungunya infection during the 2016 CHIKV outbreak in Delhi, India

  2024cites this paper
• The Natural History of Post-Chikungunya Viral Arthritis Disease Activity and T-cell Immunology: A Cohort Study

  2024cites this paper
• Acute Immunological Profile and Prognostic Biomarkers of Persistent Joint Pain in Chikungunya Fever: A Systematic Review

  2024cites this paper
• Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventions

  2024cites this paper
• Pathogenicity and virulence of O’nyong-nyong virus: A less studied Togaviridae with pandemic potential

  2024cites this paper
• Unraveling the complex interplay: immunopathology and immune evasion strategies of alphaviruses with emphasis on neurological implications

  2024influential citation
• Construction and immunogenicity of an mRNA vaccine against chikungunya virus

  2023cites this paper
• Evolución de la Enfermedad por el virus del Chikungunya en pacientes con Lupus Eritematoso Sistémico

  2023cites this paper
• A measles virus-based vaccine induces robust chikungunya virus-specific CD4+ T-cell responses in a phase II clinical trial.

  2023cites this paper
• Efficacy of interferon inducers against Chikungunya virus in vitro

  2023cites this paper
• Influence of host genetic polymorphisms involved in immune response and their role in the development of Chikungunya disease: a review

  2023cites this paper
• Innate immune response in patients with acute Chikungunya disease

  2023cites this paper
• Dengue, Chikungunya, and Zika: The Causes and Threats of Emerging and Re-emerging Arboviral Diseases

  2023influential citation
• A chikungunya virus–like particle vaccine induces broadly neutralizing and protective antibodies against alphaviruses in humans

  2023cites this paper
• Chikungunya vaccines: advances in the development and prospects for marketing approval

  2023cites this paper
• Evolution and immunopathology of chikungunya virus informs therapeutic development

  2023cites this paper
• Tropism and immune response of chikungunya and zika viruses: An overview.

  2023cites this paper
• A diversified role for γδT cells in vector-borne diseases

  2022cites this paper
• Chikungunya Immunopathology as It Presents in Different Organ Systems

  2022influential citation
• Fisetin Modulates Toll-Like Receptor-Mediated Innate Antiviral Response in Chikungunya Virus-Infected Hepatocellular Carcinoma Huh7 Cells

  2022cites this paper
• Increased Indoleamine 2,3-Dioxygenase 1 (IDO-1) Activity and Inflammatory Responses during Chikungunya Virus Infection

  2022cites this paper
• Interleukin-17 contributes to Ross River virus-induced arthritis and myositis

  2022cites this paper
• Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera

  2022cites this paper
• Increased platelet activation and platelet-inflammasome engagement during chikungunya infection

  2022cites this paper
• Human Genetic Host Factors and Its Role in the Pathogenesis of Chikungunya Virus Infection

  2022cites this paper
• Downregulation of CD73 on CD4+ T cells from patients with chronic Chikungunya infection.

  2022cites this paper
• Current Understanding of the Role of T Cells in Chikungunya, Dengue and Zika Infections

  2022cites this paper
• A high-dose inoculum size results in persistent viral infection and arthritis in mice infected with chikungunya virus

  2022cites this paper
• Synergistic Effects of Toll-Like Receptor 1/2 and Toll-Like Receptor 3 Signaling Triggering Interleukin 27 Gene Expression in Chikungunya Virus-Infected Macrophages

  2022cites this paper
• UBXN3B Controls Immunopathogenesis of Arthritogenic Alphaviruses by Maintaining Hematopoietic Homeostasis

  2022cites this paper
• Pathogenesis of chronic chikungunya arthritis: Resemblances and links with rheumatoid arthritis.

  2022cites this paper
• Chikungunya Vaccine Candidates: Current Landscape and Future Prospects

  2022cites this paper
• Distinct Cellular Tropism and Immune Responses to Alphavirus Infection.

  2022cites this paper
• DDDT_A_366112 3663..3673

  2022cites this paper
• Understanding the Biology and Immune Pathogenesis of Chikungunya Virus Infection for Diagnostic and Vaccine Development

  2022cites this paper
• Overview on Chikungunya Virus Infection: From Epidemiology to State-of-the-Art Experimental Models

  2021cites this paper
• Andrographolide - A prospective remedy for chikungunya fever and viral arthritis.

  2021cites this paper
• Alphaviruses: Host pathogenesis, immune response, and vaccine & treatment updates.

  2021cites this paper
• Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice

  2021cites this paper
• Mosquito-bite infection of humanized mice with chikungunya virus produces systemic disease with long-term effects

  2021cites this paper
• Comparative cytokine profiling identifies common and unique serum cytokine responses in acute chikungunya and dengue virus infection

  2021cites this paper
• A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial

  2021cites this paper
• Chikungunya Disease: A Concise Review and Its Transmission Model for India

  2021cites this paper
• Defining Efficacy of Chikungunya Virus Candidate Vaccines: Different Endpoints Derived From the Virus—Cytokine—Ferritin (VCF) Model

  2021cites this paper
• Chikungunya Virus: An Emergent Arbovirus to the South American Continent and a Continuous Threat to the World

  2020cites this paper
• The effects of chikungunya virus infection on people living with HIV during the 2014 Martinique outbreak

  2020cites this paper
• Construction and Immunogenicity of Recombinant Vaccinia Virus Vaccine Against Japanese Encephalitis and Chikungunya Viruses Infection in Mice

  2020cites this paper
• The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling Axis.

  2020cites this paper
• STING deficiency-associated aberrant CXCL10 expression contributes to pathogenesis of arthritogenic alphaviruses

  2020cites this paper
• Arboviruses related with chronic musculoskeletal symptoms.

  2020cites this paper
• Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections

  2020cites this paper
• Immunopathogenesis of alphaviruses.

  2020influential citation
• Disease Resolution in Chikungunya—What Decides the Outcome?

  2020influential citation
• Chikungunya Virus Evades Antiviral CD8+ T Cell Responses To Establish Persistent Infection in Joint-Associated Tissues

  2020cites this paper
• A comparison of Chikungunya virus infection, progression, and cytokine profiles in human PMA-differentiated U937 and murine RAW264.7 monocyte derived macrophages

  2020cites this paper
• Macrophage scavenger receptor 1 controls Chikungunya virus infection through autophagy in mice

  2020cites this paper
• Chikungunya virus superinfection exclusion is mediated by a block in viral replication and does not rely on non-structural protein 2

  2020cites this paper
• Mayaro Virus Infection: Clinical Features and Global Threat

  2020cites this paper
• Clinical, Virological, and Immunological Profiles of DENV, ZIKV, and/or CHIKV-Infected Brazilian Patients

  2020cites this paper
• Macrophage scavenger receptor 1 controls Chikungunya virus infection through autophagy in mice

  2020cites this paper
• Genetic polymorphisms in DC-SIGN, TLR3 and TNFa genes and the Lewis-negative phenotype are associated with Chikungunya infection and disease in Nicaragua.

  2020cites this paper
• CXCL10 Signaling Contributes to the Pathogenesis of Arthritogenic Alphaviruses

  2020cites this paper
• Role of T Cells in Chikungunya Virus Infection and Utilizing Their Potential in Anti-Viral Immunity

  2020cites this paper
• Chikungunya Virus Infection Outcome: A Systematic Review of Host Genetics

  2020cites this paper
• Ebola and Marburg Virus: A Brief Review

  2020cites this paper
• Host-Pathogen Interactions During Arboviral Infections

  2019cites this paper
• Mayaro Virus Replication Restriction and Induction of Muscular Inflammation in Mice Are Dependent on Age, Type-I Interferon Response, and Adaptive Immunity

  2019cites this paper